U.S. markets open in 1 hour 47 minutes
  • S&P Futures

    3,635.75
    +3.00 (+0.08%)
     
  • Dow Futures

    29,978.00
    -20.00 (-0.07%)
     
  • Nasdaq Futures

    12,119.50
    +43.50 (+0.36%)
     
  • Russell 2000 Futures

    1,849.00
    -2.50 (-0.14%)
     
  • Crude Oil

    45.25
    +0.34 (+0.76%)
     
  • Gold

    1,811.30
    +6.70 (+0.37%)
     
  • Silver

    23.40
    +0.10 (+0.43%)
     
  • EUR/USD

    1.1895
    -0.0001 (-0.01%)
     
  • 10-Yr Bond

    0.8820
    0.0000 (0.00%)
     
  • Vix

    21.90
    -0.76 (-3.35%)
     
  • GBP/USD

    1.3345
    -0.0013 (-0.10%)
     
  • USD/JPY

    104.4400
    -0.0400 (-0.04%)
     
  • BTC-USD

    19,214.81
    -51.84 (-0.27%)
     
  • CMC Crypto 200

    381.24
    +11.49 (+3.11%)
     
  • FTSE 100

    6,393.75
    -38.42 (-0.60%)
     
  • Nikkei 225

    26,296.86
    +131.27 (+0.50%)
     

TG Therapeutics: 3Q Earnings Snapshot

·1 min read

NEW YORK (AP) _ TG Therapeutics Inc. (TGTX) on Monday reported a loss of $87.2 million in its third quarter.

The New York-based company said it had a loss of 73 cents per share.

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 41 cents per share.

The biopharmaceutical company posted revenue of $38,000 in the period, meeting Street forecasts.

TG Therapeutics shares have more than doubled since the beginning of the year. In the final minutes of trading on Monday, shares hit $28.88, more than tripling in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TGTX at https://www.zacks.com/ap/TGTX